Moderated by: Raphael J. Landovitz, MD, MSc

Panelists: Susan P. Buchbinder, MD, Carlos del Rio, MD, Rajesh T. Gandhi, MD, Jean-Michel Molina, MD, Michael S. Saag, MD, Davey M. Smith,MD, Paul A. Volberding, MD

2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

October 29, 2020

Moderated by: Jennifer F. Hoy, MBBS

Panelists: Carlos del Rio, MD, Rajesh T. Gandhi, MD, Michael S. Saag, MD, Davey M. Smith,MD, Melanie A. Thompson, MD, Paul A. Volberding, MD

2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

October 29, 2020

Rajesh T. Gandhi, MD

2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

October 29, 2020

Lessons From the Lab: Implications for Coronavirus Vaccine and Therapeutics (October 19, 2020) by iasusa

Addressing Questions About COVID-19 (September 23, 2020) by iasusa

HIV and COVID-19 Interactions and Parallels in Advocacy (September 15, 2020) by iasusa

New Strategies and Challenges of PrEP in the COVID-19 Era (September 9, 2020) by iasusa

Continued Discussion on COVID-19 Epidemiology and Transmission (August 19, 2020) by iasusa

Joseph J. Eron, Jr, MD

IAS-USA Virtual HIV Update (Midwest)

July 30, 2020

1 hour, 5 minutes, and 35 seconds

Babafemi O. Taiwo, MBBS

IAS-USA Virtual HIV Update (East Coast)

July 30, 2020

39 minutes and 9 seconds